Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-11-9
pubmed:abstractText
To assess efficacy and safety in the treatment of nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration with intravitreal ranibizumab.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1539-2864
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1444-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19730163-Aged, pubmed-meshheading:19730163-Aged, 80 and over, pubmed-meshheading:19730163-Angiogenesis Inhibitors, pubmed-meshheading:19730163-Antibodies, Monoclonal, pubmed-meshheading:19730163-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19730163-Choroidal Neovascularization, pubmed-meshheading:19730163-Female, pubmed-meshheading:19730163-Fluorescein Angiography, pubmed-meshheading:19730163-Follow-Up Studies, pubmed-meshheading:19730163-Humans, pubmed-meshheading:19730163-Injections, pubmed-meshheading:19730163-Macular Degeneration, pubmed-meshheading:19730163-Male, pubmed-meshheading:19730163-Middle Aged, pubmed-meshheading:19730163-Retreatment, pubmed-meshheading:19730163-Retrospective Studies, pubmed-meshheading:19730163-Tomography, Optical Coherence, pubmed-meshheading:19730163-Treatment Outcome, pubmed-meshheading:19730163-Vascular Endothelial Growth Factor A, pubmed-meshheading:19730163-Visual Acuity, pubmed-meshheading:19730163-Vitreous Body
pubmed:articleTitle
A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
pubmed:affiliation
Department of Ophthalmology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain. luisarias@telefonica.net
pubmed:publicationType
Journal Article, Multicenter Study